Bleak Short-Term Outlook Overshadows Long-Term Value: Johnson Controls, Inc. (JCI), Honeywell International Inc. (HON), United Technologies Corporation (UTX)

Page 1 of 2

It’s hard to find undervalued companies in this overheated market, but there are still a few stocks suffering from an undue discount due to short-term worries.

Johnson Controls, Inc. (NYSE:JCI) is a leading auto-parts supplier that is attempting to diversify its operations away from the cyclical auto industry. The company is trying to sell one of its automotive businesses, but the near-term outlook for the business as a whole is not great.

Honeywell International Inc. (NYSE:HON)

However, with several market-leading product lines, the company is in a position to achieve long-term success.

Market Leader

Although Johnson Controls, Inc. (NYSE:JCI) is heavily involved in the automotive interiors marketplace, it also has operations in HVAC systems and vehicle batteries.

The company is by far the largest HVAC service provider in the country — nearly three times the size of the next-largest competitor. This allows for superior economies of scale that give the company a competitive advantage.

In addition, the company’s start-stop batteries are considered the market leader in an industry poised for growth. Management has also made a large bet on lithium ion batteries — an investment that has yet to play out.

Most importantly, Johnson Controls has a strong balance sheet, which provides it some protection in the case of another downturn in the auto market. However, a sale of the automotive interiors business would go a long way toward reducing this cyclical imperative.

Competition

While Johnson Controls is trying to diversify into other areas, it will continue to face competition on all fronts. Honeywell International Inc. (NYSE:HON) is involved in the automotive transportation industry, but has successfully diversified into aerospace and other areas. The company is a major supplier of systems for the Airbus A350 and is a leading company in the aerospace systems market.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!